Urology · Mesa, AZ
NPI
1750355392
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
6007 E Baseline Rd, Suite 105
Mesa, AZ, 85206
Phone (480) 897-2727
Groups this clinician bills Medicare through
Medicare paid, 2024
$485K
15,289 services
Medicare patients, 2024
1,555
Average age 77
Drug cost, 2024
$184K
3,194 prescriptions
Company payments, 2025
$656
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David J Grossklaus was code 81003 (clinical chemistry), 1,924 times for 1,254 patients. In total David J Grossklaus billed 15,289 services in 74 codes, and Medicare paid $485K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-08-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81003 Clinical Chemistry | Office | 1,924 | 1,254 | $2.19 | $4,214 |
| 99213 Office E&M - Established | Office | 1,214 | 833 | $61.99 | $75K |
| 99214 Office E&M - Established | Office | 839 | 583 | $90.37 | $76K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 482 | 59 | $137.59 | $66K |
| 99204 Office E&M - New | Office | 399 | 399 | $115.50 | $46K |
| 52000 Cystourethroscopy | Office | 379 | 283 | $169.62 | $64K |
| 51798 Ultrasound - Nonspecific | Office | 238 | 218 | $8.46 | $2,013 |
| 51702 Other Organ Systems | Office | 121 | 34 | $44.52 | $5,387 |
| 96402 Chemotherapy Administration | Office | 118 | 59 | $26.97 | $3,182 |
| 51705 Other Organ Systems | Office | 82 | 16 | $69.79 | $5,723 |
| 99459 Office/Outpatient Services | Office | 72 | 72 | $17.47 | $1,258 |
| 76872 Ultrasound - Nonspecific | Office | 59 | 56 | $106.84 | $6,304 |
| 96372 Injection Administration | Office | 57 | 50 | $11.10 | $633 |
| 51700 Other Organ Systems | Office | 54 | 51 | $52.44 | $2,832 |
| 55700 Other Organ Systems | Office | 50 | 50 | $171.92 | $8,596 |
By year: 2022 $558K for 13,248 services; 2023 $551K for 11,712 services; 2024 $485K for 15,289 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,924 | 1,254 | $2.19 | $4,214 |
Medicare prescription drug claims, 2024
In 2024, the drug David J Grossklaus prescribed most often to Medicare patients was Alfuzosin Hcl Er (Alfuzosin Hcl), with 851 prescriptions and refills. In total David J Grossklaus wrote 3,194 Medicare prescriptions that cost $184K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alfuzosin Hcl Er Alfuzosin Hcl | 851 | 2,188 | 256 | $18K |
| Tamsulosin Hcl Generic | 456 | 1,269 | 146 | $7,674 |
| Ciprofloxacin Hcl Generic | 368 | 382 | 278 | $1,769 |
| Finasteride Generic | 367 | 1,051 | 107 | $5,464 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 164 | 164 | 149 | $939 |
| Sildenafil Citrate Generic | 84 | 116 | 20 | $586 |
| Testosterone Cypionate Generic | 69 | 111 | 14 | $3,733 |
| Gemtesa Vibegron | 51 | 75 | 14 | $35K |
| Bicalutamide Generic | 47 | 87 | 22 | $1,326 |
| Testosterone Generic | 46 | 66 | Under 11 | $7,020 |
| Myrbetriq Mirabegron | 43 | 85 | 13 | $38K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 40 | 40 | 30 | $229 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 39 | 43 | 23 | $151 |
| Cephalexin Generic | 38 | 98 | 17 | $352 |
| Oxybutynin Chloride Generic | 38 | 66 | 22 | $605 |
Brand drugs: - claims; generic drugs: 3,052 claims; opioid claims: 201.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David J Grossklaus $656 ($656 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $202.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 17 | $202 |
| Sumitomo Pharma America, Inc. 4506.T | 5 | $119 |
| Boston Scientific Corporation BSX | 2 | $67.35 |
| AngioDynamics, Inc. ANGO | 1 | $49.72 |
| Ferring Pharmaceuticals Inc. | 2 | $39.18 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $29.79 |
| Calyxo, Inc. | 1 | $29.57 |
| Baxter Healthcare BAX | 1 | $27.58 |
| Bioprotect Medical, Inc. | 1 | $26.19 |
| Inspire Medical Systems, Inc. INSP | 1 | $23.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.